JPS56112907A
(en)
*
|
1980-02-12 |
1981-09-05 |
Japan Atom Energy Res Inst |
Production of polymer composition including bioactive substance
|
EP0055250B1
(en)
*
|
1980-07-01 |
1985-08-28 |
KETHARANATHAN, Vettivetpillai |
Vascular prostheses
|
US4378224A
(en)
*
|
1980-09-19 |
1983-03-29 |
Nimni Marcel E |
Coating for bioprosthetic device and method of making same
|
US4388735A
(en)
*
|
1980-11-03 |
1983-06-21 |
Shiley Inc. |
Low profile prosthetic xenograft heart valve
|
US4384374A
(en)
*
|
1981-03-27 |
1983-05-24 |
Muldashev Ernst R |
Homotransplant for layer-by-layer keratoplasty
|
US4372743A
(en)
*
|
1981-06-22 |
1983-02-08 |
American Hospital Supply Corp. |
Low-pressure fixation of valvular tissue intended for implantation
|
FR2510598A1
(fr)
*
|
1981-07-30 |
1983-02-04 |
Inst Francais Du Petrole |
Utilisation d'additifs azotes comme agents d'abaissement du point de trouble des distillats moyens d'hydrocarbures et compositions de distillats moyens d'hydrocarbures renfermant lesdits additifs
|
US4481009A
(en)
*
|
1982-05-13 |
1984-11-06 |
American Hospital Supply Corporation |
Polymer incorporation into implantable biological tissue to inhibit calcification
|
US4801299A
(en)
*
|
1983-06-10 |
1989-01-31 |
University Patents, Inc. |
Body implants of extracellular matrix and means and methods of making and using such implants
|
ZA843751B
(en)
*
|
1983-06-10 |
1984-12-24 |
University Patents Inc |
Body implants of extracellular matrix and means and methods of making and using such implants
|
US4681588A
(en)
*
|
1983-10-20 |
1987-07-21 |
Vettivetpillai Ketharanathan |
Biomaterial
|
US4553974A
(en)
*
|
1984-08-14 |
1985-11-19 |
Mayo Foundation |
Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
|
NO166836C
(no)
*
|
1985-03-14 |
1991-09-11 |
Univ California |
Fremgangsmaate for behandling av et organtransplantat.
|
US4770665A
(en)
*
|
1985-11-05 |
1988-09-13 |
American Hospital Supply Corporation |
Elastomeric polymer incorporation into implantable biological tissue to inhibit calcification
|
US4729139A
(en)
*
|
1985-11-05 |
1988-03-08 |
Baxter Travenol |
Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
|
AU586718B2
(en)
*
|
1985-11-13 |
1989-07-20 |
Domedica Pty. Limited |
Treatment of collagenous tissue
|
US4786287A
(en)
*
|
1986-10-10 |
1988-11-22 |
Baxter Travenol Laboratories |
Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
|
US4813964A
(en)
*
|
1986-10-14 |
1989-03-21 |
Hancock Jaffe Laboratories |
Crosslinked anisotropic xenogeneic diaphragm tissue in flexor tendon pulley reconstruction
|
US5139527A
(en)
*
|
1987-12-17 |
1992-08-18 |
Immuno Aktiengesellschaft |
Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation
|
EP0364517B1
(en)
*
|
1988-02-03 |
1994-04-06 |
Biomedical Design, Inc. |
Prevention of prosthesis calcification
|
AT398276B
(de)
*
|
1989-05-31 |
1994-11-25 |
Sorin Biomedica Spa |
Verfahren zur präparierung von biologischem implantationsmaterial
|
US5283058A
(en)
|
1990-08-30 |
1994-02-01 |
The General Hospital Corporation |
Methods for inhibiting rejection of transplanted tissue
|
US5374539A
(en)
*
|
1991-06-17 |
1994-12-20 |
Nimni; Marcel E. |
Process for purifying collagen and generating bioprosthesis
|
WO1993010722A2
(en)
*
|
1991-11-26 |
1993-06-10 |
Research Development Foundation |
Fetal membrane tubes for nerve and vessel grafts
|
US5342387A
(en)
*
|
1992-06-18 |
1994-08-30 |
American Biomed, Inc. |
Artificial support for a blood vessel
|
US5437287A
(en)
*
|
1992-08-17 |
1995-08-01 |
Carbomedics, Inc. |
Sterilization of tissue implants using iodine
|
WO1994028897A2
(en)
*
|
1993-06-07 |
1994-12-22 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
|
US6203755B1
(en)
|
1994-03-04 |
2001-03-20 |
St. Jude Medical, Inc. |
Electron beam sterilization of biological tissues
|
US5443824A
(en)
*
|
1994-03-14 |
1995-08-22 |
Piacquadio; Daniel J. |
Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
|
US5595571A
(en)
*
|
1994-04-18 |
1997-01-21 |
Hancock Jaffe Laboratories |
Biological material pre-fixation treatment
|
USRE40570E1
(en)
|
1994-07-29 |
2008-11-11 |
Edwards Lifesciences Corporation |
Apparatuses and methods for treating biological tissue to mitigate calcification
|
US5931969A
(en)
|
1994-07-29 |
1999-08-03 |
Baxter International Inc. |
Methods and apparatuses for treating biological tissue to mitigate calcification
|
DE69523074T2
(de)
*
|
1994-07-29 |
2002-06-06 |
Edwards Lifesciences Corp., Irvine |
Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
|
US5782931A
(en)
*
|
1996-07-30 |
1998-07-21 |
Baxter International Inc. |
Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
|
US6152142A
(en)
*
|
1997-02-28 |
2000-11-28 |
Tseng; Scheffer C. G. |
Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
|
US5891196A
(en)
*
|
1997-04-16 |
1999-04-06 |
Baxter International Inc. |
Method for actively binding heparin to crosslinked biological tissues
|
US5958669A
(en)
*
|
1997-05-02 |
1999-09-28 |
St. Jude Medical, Inc. |
Apparatus and method for crosslinking to fix tissue or crosslink molecules to tissue
|
US6008292A
(en)
*
|
1997-12-02 |
1999-12-28 |
Baxter International Inc. |
Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
|
US6214054B1
(en)
|
1998-09-21 |
2001-04-10 |
Edwards Lifesciences Corporation |
Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
|
US6214055B1
(en)
*
|
1998-10-30 |
2001-04-10 |
Mures Cardiovascular Research, Inc. |
Method and kit for rapid preparation of autologous tissue medical devices
|
US6524339B1
(en)
|
1999-01-27 |
2003-02-25 |
David H. Adams |
Cryopreserved homografts and other stentless bioprosthetic heart valves having natural tissue sewing rings
|
US6471723B1
(en)
|
2000-01-10 |
2002-10-29 |
St. Jude Medical, Inc. |
Biocompatible prosthetic tissue
|
AU5380201A
(en)
*
|
2000-04-27 |
2001-11-07 |
Ray Jui Fang Tsai |
Method for expansion of epithelial stem cells
|
CA2411102A1
(en)
|
2000-06-20 |
2001-12-27 |
Idec Pharmaceutical Corporation |
Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination
|
WO2002059114A1
(en)
*
|
2000-11-28 |
2002-08-01 |
Genentech, Inc. |
Lfa-1 antagonist compounds
|
US20020159996A1
(en)
|
2001-01-31 |
2002-10-31 |
Kandasamy Hariharan |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
EP1370292A1
(en)
|
2001-01-31 |
2003-12-17 |
Idec Pharmaceuticals Corporation |
Use of cd23 antagonists for the treatment of neoplastic disorders
|
US6878168B2
(en)
|
2002-01-03 |
2005-04-12 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
US8308797B2
(en)
|
2002-01-04 |
2012-11-13 |
Colibri Heart Valve, LLC |
Percutaneously implantable replacement heart valve device and method of making same
|
CN1705439A
(zh)
*
|
2002-04-12 |
2005-12-07 |
细胞基因公司 |
干细胞和祖细胞分化的调节、鉴定及其应用
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
EP1572744B1
(en)
|
2002-12-16 |
2010-06-09 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
NZ587776A
(en)
|
2003-04-09 |
2012-03-30 |
Genentech Inc |
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor using anti-CD20 antibody
|
WO2005115453A2
(en)
*
|
2004-04-16 |
2005-12-08 |
Genentech, Inc. |
Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies
|
RU2006140377A
(ru)
*
|
2004-04-16 |
2008-05-27 |
Дженентек, Инк. (Us) |
Способ усиления уничтожения в-клеток
|
AU2005249566B2
(en)
|
2004-06-04 |
2010-11-11 |
Genentech, Inc. |
Method for treating multiple sclerosis
|
SV2006002342A
(es)
*
|
2004-12-17 |
2006-06-01 |
Genentech Inc |
Terapia de antiogenesis para enfermedades autoinmunes en pacientes que tuvieron la terapia anterior interrumpida
|
US20060263357A1
(en)
|
2005-05-05 |
2006-11-23 |
Tedder Thomas F |
Anti-CD19 antibody therapy for autoimmune disease
|
CA2597924C
(en)
|
2005-02-15 |
2018-10-02 |
Duke University |
Anti-cd19 antibodies and uses in oncology
|
TW200714289A
(en)
*
|
2005-02-28 |
2007-04-16 |
Genentech Inc |
Treatment of bone disorders
|
EP1869076A2
(en)
|
2005-03-10 |
2007-12-26 |
Genentech, Inc. |
Methods and compositions for modulating vascular integrity
|
US7579381B2
(en)
*
|
2005-03-25 |
2009-08-25 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
WO2007038686A2
(en)
|
2005-09-27 |
2007-04-05 |
Tissuetech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
US8389688B2
(en)
|
2006-03-06 |
2013-03-05 |
Aeres Biomedical, Ltd. |
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
CN101626682B
(zh)
|
2006-10-27 |
2014-04-16 |
爱德华兹生命科学公司 |
用于外科植入的生物组织
|
AU2008247382B2
(en)
|
2007-05-07 |
2014-06-05 |
Medimmune, Llc |
Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
US9101691B2
(en)
|
2007-06-11 |
2015-08-11 |
Edwards Lifesciences Corporation |
Methods for pre-stressing and capping bioprosthetic tissue
|
US9233107B2
(en)
|
2007-09-14 |
2016-01-12 |
Biogen Ma Inc. |
Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (PML)
|
JP5490714B2
(ja)
*
|
2007-11-28 |
2014-05-14 |
メディミューン,エルエルシー |
タンパク質製剤
|
US8357387B2
(en)
|
2007-12-21 |
2013-01-22 |
Edwards Lifesciences Corporation |
Capping bioprosthetic tissue to reduce calcification
|
WO2009111085A1
(en)
*
|
2008-03-07 |
2009-09-11 |
Biogen Idec Ma Inc. |
Use of cd23 antibodies to treat malignancies in patients with poor prognosis
|
US9358320B2
(en)
|
2008-04-25 |
2016-06-07 |
Allosource |
Multi-layer tissue patches
|
EP2282749A4
(en)
*
|
2008-04-25 |
2011-08-17 |
Allosource |
ANTI-ADHESIVE BARRIER DRESSING COMPRISING A TREATED AMNIOTIC FABRIC AND METHOD OF USE
|
US9480549B2
(en)
|
2008-04-25 |
2016-11-01 |
Allosource |
Multi-layer tissue patches
|
EP2313111B1
(en)
|
2008-08-01 |
2013-09-04 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
CA2739663A1
(en)
*
|
2008-10-10 |
2010-05-15 |
Anaphore, Inc. |
Polypeptides that bind trail-r1 and trail-r2
|
CN102438652B
(zh)
|
2008-11-12 |
2014-08-13 |
米迪缪尼有限公司 |
抗体制剂
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
SG175004A1
(en)
|
2009-04-02 |
2011-11-28 |
Roche Glycart Ag |
Multispecific antibodies comprising full length antibodies and single chain fab fragments
|
EP2459591B1
(en)
|
2009-07-31 |
2014-08-20 |
Genentech, Inc. |
Inhibition of tumor metastasis using anti-g-csf-antibodies
|
WO2011034605A2
(en)
|
2009-09-16 |
2011-03-24 |
Genentech, Inc. |
Coiled coil and/or tether containing protein complexes and uses thereof
|
WO2011033006A1
(en)
|
2009-09-17 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Methods and compositions for diagnostics use in cancer patients
|
US20110086770A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Combinatorial Libraries Based on C-type Lectin-like Domain
|
WO2011060015A1
(en)
|
2009-11-11 |
2011-05-19 |
Genentech, Inc. |
Methods and compositions for detecting target proteins
|
CN102770456B
(zh)
|
2009-12-04 |
2018-04-06 |
弗·哈夫曼-拉罗切有限公司 |
多特异性抗体、抗体类似物、组合物和方法
|
BR122014006876B1
(pt)
|
2010-03-23 |
2020-09-29 |
Edwards Lifesciences Corporation |
Método para preparar material de membrana de tecido bioprotético
|
AR080793A1
(es)
|
2010-03-26 |
2012-05-09 |
Roche Glycart Ag |
Anticuerpos biespecificos
|
TWI586806B
(zh)
|
2010-04-23 |
2017-06-11 |
建南德克公司 |
異多聚體蛋白質之製造
|
US8906601B2
(en)
|
2010-06-17 |
2014-12-09 |
Edwardss Lifesciences Corporation |
Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
|
JP5758004B2
(ja)
|
2010-08-24 |
2015-08-05 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ジスルフィドによって安定化されたFv断片を含む二重特異性抗体
|
SG189071A1
(en)
|
2010-10-01 |
2013-05-31 |
Ventirx Pharmaceuticals Inc |
Therapeutic use of a tlr agonist and combination therapy
|
WO2012064627A2
(en)
|
2010-11-08 |
2012-05-18 |
Genentech, Inc. |
Subcutaneously administered anti-il-6 receptor antibody
|
US9351829B2
(en)
|
2010-11-17 |
2016-05-31 |
Edwards Lifesciences Corporation |
Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
|
WO2012085111A1
(en)
|
2010-12-23 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
CA2825064C
(en)
|
2011-02-04 |
2022-08-30 |
Genentech, Inc. |
Fc variants and methods for their production
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
US20120203254A1
(en)
*
|
2011-02-07 |
2012-08-09 |
David Tak Wai Chiu |
Allogenic Vessel Nerve Conduit
|
JP6248029B2
(ja)
|
2011-03-31 |
2017-12-13 |
ジェネンテック, インコーポレイテッド |
ベータ7インテグリンアンタゴニストの投与方法
|
WO2012170905A1
(en)
|
2011-06-10 |
2012-12-13 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
US9358107B2
(en)
|
2011-06-30 |
2016-06-07 |
Edwards Lifesciences Corporation |
Systems, dies, and methods for processing pericardial tissue
|
KR101786862B1
(ko)
|
2011-07-04 |
2017-10-18 |
메소블라스트, 아이엔씨. |
류마티즘성 질환을 치료 또는 예방하는 방법
|
WO2013013708A1
(en)
|
2011-07-26 |
2013-01-31 |
Fundació Institut D'investigació Biomèdica De Bellvitge |
Treatment of acute rejection in renal transplant
|
CA2842481A1
(en)
|
2011-08-17 |
2013-02-21 |
Genentech, Inc. |
Inhibition of angiogenesis in refractory tumors
|
US9585983B1
(en)
|
2011-10-12 |
2017-03-07 |
BioDlogics, LLC |
Wound covering and method of preparation
|
WO2013082511A1
(en)
|
2011-12-02 |
2013-06-06 |
Genentech, Inc. |
Methods for overcoming tumor resistance to vegf antagonists
|
WO2013101771A2
(en)
|
2011-12-30 |
2013-07-04 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
EP2809684A1
(en)
|
2012-01-31 |
2014-12-10 |
Genentech, Inc. |
Anti-ig-e m1' antibodies and methods using same
|
BR112014019579A2
(pt)
|
2012-02-10 |
2019-10-15 |
Genentech, Inc |
Anticorpo de cadeia única, polinucleotídeo, vetor, célula hospedeira, método de produção de um anticorpo de cadeia única, heteromultímero e método de produção do heteromultímero
|
RU2659423C2
(ru)
|
2012-02-16 |
2018-07-02 |
ЭйТИР ФАРМА, ИНК. |
ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
|
ES2597228T3
(es)
|
2012-06-27 |
2017-01-17 |
F. Hoffmann-La Roche Ag |
Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
|
BR112014028368A2
(pt)
|
2012-06-27 |
2017-11-14 |
Hoffmann La Roche |
método de produção de conjugado de região fc de anticorpo, conjugado de região fc de anticorpo e formulação farmacêutica
|
US10238771B2
(en)
|
2012-11-08 |
2019-03-26 |
Edwards Lifesciences Corporation |
Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
|
US10905800B1
(en)
|
2013-01-29 |
2021-02-02 |
BioDlogics, LLC |
Ocular covering and method of use
|
CN105247072B
(zh)
|
2013-02-25 |
2019-10-15 |
基因泰克公司 |
检测和治疗抗药性akt突变体的方法和组合物
|
US9498327B1
(en)
|
2013-03-05 |
2016-11-22 |
Biodlogics Llc |
Repair of tympanic membrane using human birth tissue material
|
US9789138B1
(en)
|
2013-03-06 |
2017-10-17 |
BioDlogics, LLC |
Neural repair construct and method of use
|
US9770472B1
(en)
|
2013-03-08 |
2017-09-26 |
Brahm Holdings, Llc |
Organ jacket and methods of use
|
US9855301B1
(en)
|
2013-03-13 |
2018-01-02 |
Biodlogics Llc |
Human birth tissue laminate and methods of use
|
US9682071B2
(en)
|
2013-03-15 |
2017-06-20 |
Intermune, Inc. |
Methods of improving microvascular integrity
|
US9795638B1
(en)
|
2013-03-16 |
2017-10-24 |
BioDlogics, LLC |
Cardiothoracic construct and methods of use
|
BR112015024856A2
(pt)
|
2013-03-27 |
2018-04-17 |
Genentech Inc |
métodos de determinação ou de monitoramento
|
US9615922B2
(en)
|
2013-09-30 |
2017-04-11 |
Edwards Lifesciences Corporation |
Method and apparatus for preparing a contoured biological tissue
|
US10959839B2
(en)
|
2013-10-08 |
2021-03-30 |
Edwards Lifesciences Corporation |
Method for directing cellular migration patterns on a biological tissue
|
WO2015148809A1
(en)
|
2014-03-27 |
2015-10-01 |
Genentech, Inc. |
Methods for diagnosing and treating inflammatory bowel disease
|
HRP20231139T1
(hr)
|
2014-05-06 |
2024-01-05 |
F. Hoffmann - La Roche Ag |
Proizvodnja heteromultimernih proteina upotrebom stanica sisavaca
|
EP3693391A1
(en)
|
2014-09-12 |
2020-08-12 |
Genentech, Inc. |
Anti-cll-1 antibodies and immunoconjugates
|
US10265438B1
(en)
|
2014-11-03 |
2019-04-23 |
BioDlogics, LLC |
Methods and compositions for the repair and replacement of connective tissue
|
WO2016087416A1
(en)
|
2014-12-03 |
2016-06-09 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|
TWI713480B
(zh)
|
2014-12-05 |
2020-12-21 |
美商建南德克公司 |
抗CD79b抗體及其使用方法
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
EP3978530A1
(en)
|
2015-02-26 |
2022-04-06 |
F. Hoffmann-La Roche AG |
Integrin beta7 antagonists and methods of treating crohn's disease
|
EP3310378B1
(en)
|
2015-06-16 |
2024-01-24 |
F. Hoffmann-La Roche AG |
Anti-cll-1 antibodies and methods of use
|
PE20221007A1
(es)
|
2015-06-24 |
2022-06-15 |
Hoffmann La Roche |
Anticuerpos anti-receptor de transferrina con afinidad disenada
|
CA2989936A1
(en)
|
2015-06-29 |
2017-01-05 |
Genentech, Inc. |
Type ii anti-cd20 antibody for use in organ transplantation
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
UA127887C2
(uk)
|
2015-10-02 |
2024-02-07 |
Ф. Хоффманн-Ля Рош Аг |
Біспецифічне антитіло до людського cd20/людського рецептора трансферину та способи його застосування
|
JP2018529747A
(ja)
|
2015-10-06 |
2018-10-11 |
ジェネンテック, インコーポレイテッド |
多発性硬化症を治療するための方法
|
US10525137B2
(en)
|
2015-12-30 |
2020-01-07 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
ES2858151T3
(es)
|
2016-05-20 |
2021-09-29 |
Hoffmann La Roche |
Conjugados de PROTAC-anticuerpo y procedimientos de uso
|
WO2018007849A1
(en)
|
2016-07-05 |
2018-01-11 |
Carlos Alvarado |
Serous membrane for ocular surface disorders
|
EP3551046B1
(en)
|
2016-12-07 |
2023-07-19 |
Biora Therapeutics, Inc. |
Gastrointestinal tract detection methods, devices and systems
|
WO2018112232A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device
|
BR112019012062A2
(pt)
|
2016-12-14 |
2019-11-12 |
Progenity Inc |
tratamento de uma doença do trato gastrointestinal com um inibidor de jak e dispositivos
|
EP3554345A1
(en)
|
2016-12-14 |
2019-10-23 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a smad7 inhibitor
|
CA3045310A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
WO2018112223A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with a tlr modulator
|
EP3554342B1
(en)
|
2016-12-14 |
2024-07-24 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a tnf inhibitor
|
WO2018112237A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor
|
AU2017378406A1
(en)
|
2016-12-14 |
2019-06-13 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with an immunosuppressant
|
CA3054159A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
|
WO2018183931A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
|
AU2018244922A1
(en)
|
2017-03-30 |
2019-09-12 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with live biotherapeutics
|
WO2018183932A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
|
WO2018222434A1
(en)
|
2017-05-31 |
2018-12-06 |
Edwards Lifesciences Corporation |
Collagen fibers and articles formed therefrom
|
CN117338932A
(zh)
|
2017-08-23 |
2024-01-05 |
科智生命科学公司 |
自身免疫性病症的治疗中的免疫蛋白酶体抑制剂和免疫抑制剂
|
RU2698048C2
(ru)
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
CN111491675A
(zh)
|
2018-01-23 |
2020-08-04 |
爱德华兹生命科学公司 |
用于预拉伸可植入生物相容性材料的方法及其生产的材料和装置
|
WO2019147824A1
(en)
|
2018-01-26 |
2019-08-01 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
|
AU2019278927A1
(en)
|
2018-06-01 |
2020-12-24 |
Biora Therapeutics, Inc. |
Devices and systems for gastrointestinal microbiome detection and manipulation
|
US20230009902A1
(en)
|
2018-06-20 |
2023-01-12 |
Progenity, Inc. |
Treatment of a disease or condition in a tissue orginating from the endoderm
|
US11103619B2
(en)
|
2018-08-30 |
2021-08-31 |
Efstathios-Andreas AGATHOS |
Anticalcification treatment for impantable biological tissues using calcitonin
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
TW202037381A
(zh)
|
2018-10-24 |
2020-10-16 |
瑞士商赫孚孟拉羅股份公司 |
綴合化學降解誘導劑及使用方法
|
RU2724469C2
(ru)
|
2018-10-31 |
2020-06-23 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с cd20
|
CN113164258A
(zh)
|
2018-11-01 |
2021-07-23 |
爱德华兹生命科学公司 |
经导管再生肺动脉瓣
|
EP3883634A1
(en)
|
2018-11-19 |
2021-09-29 |
Progenity, Inc. |
Methods and devices for treating a disease with biotherapeutics
|
US20220364171A1
(en)
|
2018-11-23 |
2022-11-17 |
Katholieke Universiteit Leuven |
Predicting a treatment response in inflammatory bowel disease
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
WO2020162978A1
(en)
|
2019-02-06 |
2020-08-13 |
Sangamo Therapeutics, Inc. |
Method for the treatment of mucopolysaccharidosis type i
|
BR112021019448A2
(pt)
|
2019-04-02 |
2021-11-30 |
Sangamo Therapeutics Inc |
Métodos para o tratamento de beta-talassemia
|
CN115666704A
(zh)
|
2019-12-13 |
2023-01-31 |
比奥拉治疗股份有限公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
TW202330613A
(zh)
|
2021-11-12 |
2023-08-01 |
美商建南德克公司 |
使用整聯蛋白β7拮抗劑治療克隆氏病之方法
|
WO2024127332A1
(en)
|
2022-12-14 |
2024-06-20 |
Pheon Therapeutics Ltd |
Cytotoxic compounds
|